Kalaris Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Kalaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kalaris Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kalaris Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $289 | 50 | 5.78 |
| 2025-03-31 | $2.4k | 295 | 8.02 |